Cargando…

Efficacy and Safety of Qinpi Tongfeng Formula in the Treatment of Acute Gouty Arthritis: A Double-Blind, Double-Dummy, Multicenter, Randomized Controlled Trial

OBJECTIVE: Traditional Chinese medicine (TCM) has certain curative effect against acute gouty arthritis (AGA), but it lacks high-quality evidence-based studies. In this randomized controlled trial, we try to evaluate the clinical efficacy and safety of Qinpi Tongfeng Formula (QPTFF) in the treatment...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fan, Yihua, Liu, Wei, Lu, Hang, Liu, Jian, Wu, Rui, Zhao, Jun, Wang, Aihua, Zhang, Xianheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9296295/ https://www.ncbi.nlm.nih.gov/pubmed/35865342 http://dx.doi.org/10.1155/2022/7873426

Ejemplares similares

Efficacy and Safety of Qinpi Tongfeng Formula Combined with Bloodletting Therapy in the Treatment of Acute Gouty Arthritis: A Study Protocol for a Randomized Controlled Trial
por: Lu, Hang, et al.
Publicado: (2022)

Chinese Medicine Huzhen Tongfeng Formula Effectively Attenuates Gouty Arthritis by Inhibiting Arachidonic Acid Metabolism and Inflammatory Mediators
por: Deng, Jianping, et al.
Publicado: (2020)

Chuanhu Anti-Gout Mixture versus Colchicine for Acute Gouty Arthritis: A Randomized, Double-Blind, Double-Dummy, Non-Inferiority Trial
por: Wang, YanGang, et al.
Publicado: (2014)

Huzhang Tongfeng Granule Improves Monosodium Urate-Induced Inflammation of Gouty Arthritis Rat Model by Downregulation of Cyr61 and Related Cytokines
por: Zhou, Mi, et al.
Publicado: (2020)

Efficacy of the Jingxin Zhidong Formula for Tic Disorders: A Randomized, Double Blind, Double Dummy, Parallel Controlled Trial
por: Fan, Fei, et al.
Publicado: (2022)

A double-blind, double-dummy, randomized controlled, multicenter trial of (99)Tc-methylene diphosphonate in patients with moderate to severe rheumatoid arthritis
por: Fu, Qiong, et al.
Publicado: (2021)

The Independent Value of Neutrophil to Lymphocyte Ratio in Gouty Arthritis: A Narrative Review
por: Chen, Yiming, et al.
Publicado: (2023)

Efficacy and safety of Tibetan medicine Qingpeng ointment for acute gouty arthritis: protocol for a multi-center, randomized, double-blind, placebo-controlled trial
por: Shang, Ya-xi, et al.
Publicado: (2022)

Oral Huzhang granules for the treatment of acute gouty arthritis: protocol for a double-blind, randomized, controlled trial
por: Zhou, Mi, et al.
Publicado: (2022)

A Randomized Double-Blind, Double-Dummy, Multicenter Trial of Azasetron versus Ondansetron to Evaluate Efficacy and Safety in the Prevention of Delayed Nausea and Vomiting Induced by Chemotherapy
por: Lee, Hee Yeon, et al.
Publicado: (2014)

Treatment of Bacterial Vaginosis: A Multicenter, Double-Blind, Double-Dummy, Randomised Phase III Study Comparing Secnidazole and Metronidazole
por: Bohbot, Jean-Marc, et al.
Publicado: (2010)

Early urate-lowering therapy in gouty arthritis with acute flares: a double-blind placebo controlled clinical trial
por: Yang, Deng-Ho, et al.
Publicado: (2023)

Efficacy and safety of Shu-gan-qing-re formula for generalized anxiety disorder: study protocol for a multi-center, prospective, double-blind, double-dummy, randomized controlled trial
por: Chen, Pei, et al.
Publicado: (2020)

Tenofovir disoproxil fumarate in Chinese chronic hepatitis B patients: Results of a multicenter, double-blind, double-dummy, clinical trial at 96 weeks
por: Chen, Xiao-Fan, et al.
Publicado: (2021)

Canakinumab reduces the risk of acute gouty arthritis flares during initiation of allopurinol treatment: results of a double-blind, randomised study
por: Schlesinger, Naomi, et al.
Publicado: (2011)

Comparison of the efficacy and safety of CELBESTA® versus CELEBREX® in patients with rheumatoid arthritis: a 6-week, multicenter, double-blind, double-dummy, active-controlled, randomized, parallel-group, non-inferiority phase 4 clinical trial
por: Kim, Hyun-Sook, et al.
Publicado: (2020)

The efficacy and safety of pramipexole ER versus IR in Chinese patients with Parkinson’s disease: a randomized, double-blind, double-dummy, parallel-group study
por: Wang, Ying, et al.
Publicado: (2014)

Menatetrenone versus alfacalcidol in the treatment of Chinese postmenopausal women with osteoporosis: a multicenter, randomized, double-blinded, double-dummy, positive drug-controlled clinical trial
por: Jiang, Yan, et al.
Publicado: (2014)

A Double‐Blind, Double‐Dummy, Flexible‐Design Randomized Multicenter Trial: Early Safety of Single‐ Versus Divided‐Dose Rabbit Anti‐Thymocyte Globulin Induction in Renal Transplantation
por: Stevens, R. B., et al.
Publicado: (2016)

Effect of an Echinacea-Based Hot Drink Versus Oseltamivir in Influenza Treatment: A Randomized, Double-Blind, Double-Dummy, Multicenter, Noninferiority Clinical Trial
por: Rauš, Karel, et al.
Publicado: (2015)

Zabofloxacin versus moxifloxacin in patients with COPD exacerbation: a multicenter, double-blind, double-dummy, randomized, controlled, Phase III, non-inferiority trial
por: Rhee, Chin Kook, et al.
Publicado: (2015)

Xiaoketongbi Formula vs pregabalin for painful diabetic neuropathy: A single‐center, randomized, single‐blind, double‐dummy, and parallel controlled clinical trial
por: Lu, Qiyun, et al.
Publicado: (2022)

Efficacy and Safety of Zhuanggu Joint Capsules in Combination with Celecoxib in Knee Osteoarthritis: A Multi-center, Randomized, Double-blind, Double-dummy, and Parallel Controlled Trial
por: Zhang, Xian-Long, et al.
Publicado: (2016)

Efficacy and Safety of Naftopidil in Patients With Neurogenic Lower Urinary Tract Dysfunction: An 8-Week, Active-Controlled, Stratified-Randomized, Double-Blind, Double-Dummy, Parallel Group, Noninferiority, Multicenter Design
por: Sung, Hyun Hwan, et al.
Publicado: (2020)

The safety and efficacy of CKD-497 in patients with acute upper respiratory tract infection and bronchitis symptoms: a multicenter, double-blind, double-dummy, randomized, controlled, phase II clinical trial
por: Ra, Seung Won, et al.
Publicado: (2021)

A 6-week, multicentre, randomised, double-blind, double-dummy, active-controlled, clinical safety study of lumiracoxib and rofecoxib in osteoarthritis patients
por: Stricker, Kirstin, et al.
Publicado: (2008)

Efficacy and safety of suanzaoren decoction for chronic insomnia disorder in adults: study protocol for randomised, double-blind, double-dummy, placebo-controlled trial
por: Zhou, Qi-Hui, et al.
Publicado: (2017)

Efficacy and Safety of Tangshen Formula on Patients with Type 2 Diabetic Kidney Disease: A Multicenter Double-Blinded Randomized Placebo-Controlled Trial
por: Li, Ping, et al.
Publicado: (2015)

Jintiange combined with alfacalcidol improves muscle strength and balance in primary osteoporosis: A randomized, double-blind, double-dummy, positive-controlled, multicenter clinical trial
por: Liang, Hanting, et al.
Publicado: (2022)

Comparison of Two pMDIs in Adult Asthmatics: A Randomized Double-Blind Double-Dummy Clinical Trial
por: Nam, Tae-Hyun, et al.
Publicado: (2022)

Efficacy and safety of fire-needle in the treatment of gouty arthritis: A protocol for systematic review and meta analysis
por: Sun, Jiya, et al.
Publicado: (2020)

Efficacy and safety of Reduqing granules in the treatment of common cold with wind-heat syndrome: a randomized, double-blind, double-dummy, positive-controlled trial
por: Yanjiao, Ma, et al.
Publicado: (2017)

Integrated Molecular Docking with Network Pharmacology to Reveal the Molecular Mechanism of Simiao Powder in the Treatment of Acute Gouty Arthritis
por: Fan, Yihua, et al.
Publicado: (2021)

Autoinflammatory Features in Gouty Arthritis
por: Galozzi, Paola, et al.
Publicado: (2021)

A randomized, double-blind, double-dummy, controlled, multicenter study of Qingzhong (tenofovir disoproxil fumarate) versus Viread for the treatment of chronic hepatitis B: First-stage results at week 48
por: Liang, Rong-Yue, et al.
Publicado: (2019)

Compound Danshen Dripping Pill for Treating Early Diabetic Retinopathy: A Randomized, Double-Dummy, Double-Blind Study
por: Luo, Dan, et al.
Publicado: (2015)

A randomized, double-blinded, double-dummy efficacy and safety study of budesonide–formoterol Spiromax® compared to budesonide–formoterol Turbuhaler® in adults and adolescents with persistent asthma
por: Virchow, J. Christian, et al.
Publicado: (2016)

The efficacy and safety of continued hydroxycarbamide therapy versus switching to ruxolitinib in patients with polycythaemia vera: a randomized, double‐blind, double‐dummy, symptom study (RELIEF)
por: Mesa, Ruben, et al.
Publicado: (2016)

A randomized double-blind placebo-controlled multicenter trial of Bushen Yisui and Ziyin Jiangzhuo formula for constipation in Parkinson disease
por: Jin, Zhaohui, et al.
Publicado: (2020)

A multicenter, randomized, double-blind, placebo-controlled trial evaluating the efficacy and safety of Huangqi Guizhi Wuwutang granule in patients with rheumatoid arthritis
por: Wang, Yiru, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_9fkvb23rhnmp9i3mntaoej2i19